8/9/2019 Value To__Strategic Partners.pptx

1/12

Diabetic NephropathyDiabetic RetinopathyHypercholesterolemiaOral MucositisGoutAcute Lymphocytic LeukemiaBone MetastasisBrain CancerBreast CancerCervical CancerChronic Lymphocytic LeukemiaEn ometrial CancerE!in" #arcomaGastric CancerGastrointestinal #tromal $umors

Hea An Neck CancerHo "kin Lymphoma%i ney CancerLiver CancerMali"nant MesotheliomaMe ullary $hyroi CancerMelanomaMultiple MyelomaNon&Ho "kin LymphomaNonmall Cell Lun" CancerOvarian Cancer'ancreatic Cancer$esticular Cancer$hyroi CancerA"e Relate Macular De"eneration%eratocon(unctivitis sicca )Dry Eye*Retinal +ein OcclusionAcute Respiratory Distress#yn rome#epsis#taphylococcal ,n-ectionsAcute Coronary #yn romeAn"ina 'ectorisAtrial .ibrillationCoronary Artery Disease )CAD*Critical Limb ,schemiaHypertension'ulmonary Arterial HypertensionAcute 'ainAn/iety Disor ersChronic 'ainDementiaDiabetic Neuropathy

Obsessive&Compulsive Disor erOsteoarthritis 'ain'arkinson0s Disease'ost&$raumatic #tress Disor erRestless Le"s #yn rome#chi1ophrenia$raumatic Brain ,n(uryLiver CirrhosisChil hoo EnuresisGro!th Hormone Disor ersHyperparathyroi ismHyperthyroi ismGuillain&Barre #yn romeCytome"alovirus.un"al ,n-ectionsGram&Ne"ative Bacterial ,n-ections

H2N2 ,n-ectionHerpes 3osterH,+&2 ,n-ectionHuman 'apillomavirus ,n-ections#taphylococcus Aureus )MR#A*

Car iovascular Devices'rosthetic Heart +alve

'eripheral +ascular DevicesCar iovascular Monitorin" 4 Dia"nostic Devices

Car iovascular #ur"eryCar iac Rhythm Mana"ement

Car iovascular 'rosthetic Devices,nterventional Car iolo"y

Car iac Assist Devices5oun Care Mana"ement

Hospital #upplies#yrin"es an Nee les

Disposable Hospital 4 #ur"ical #uppliesDru" Delivery Devices

,nhalation #ystemsNee le .ree ,n(ections

,n-usion #ystemsDiabetes Care Devices

,nsulin Delivery 4 Glucose Monitorin"Ophthalmic Devices

Cataract #ur"ery DevicesOphthalmic Dia"nostic E6uipment

Re-ractive #ur"ery DevicesEN$ Devices

Hearin" ,mplantsDia"nostic Devices

Electrosur"ical DevicesDental E6uipment 4 Accessories

Dia"nostic ,ma"in" 4 MR, #ystemsC7$ #ystems 4 Mammo"raphy E6uipment

8&Ray 4 9ltrasoun #ystems

Nuclear ,ma"in" E6uipmentContrast Me ia ,n(ectorsBone Densitometry

Anesthesia an Respiratory DevicesAnesthesia Machines 4 Disposables

Respiratory Devices 4 Disposables#leep Apnea Dia"nostic #ystems

Healthcare ,$Me ical ,ma"in" ,n-ormation #ystems

Nephrolo"y an 9rolo"y DevicesRenal Dialysis E6uipment

Orthope ic DevicesOrthobiolo"ics 4 Arthroscopy

:oint Reconstruction$rauma .i/ation

Orthope ic 'rostheticsCranium Ma/illo-acial .i/ation )CM.*

#pinal #ur"eryEn oscopy Devices 4 instruments

Ri"i 4 .le/ible En oscope,n +itro Dia"nostics

Genetic $estin"Clinical Chemistry

Hematolo"y,mmuno Chemistry

,n-ectious ,mmunolo"yHistolo"y An Cytolo"y

'atient Monitorin"Multiparameter 'atient Monitorin"Micro&Electromechanical #ystems

Non&invasive Bloo 'ressure MonitorsNeurolo"y Devices

Neurostimulation Devices,nterventional Neurolo"y

C#. Mana"ementNeurosur"ical 'ro ucts

Ra iosur"ery

M E D T E C H

& D

I A G N O S T I C S

B I O P H

A R M A C E U T I C A L S

Value to theStrategic Part er

8/9/2019 Value To__Strategic Partners.pptx

2/12

Healthcares Investment Bank

!"#$% Glo&al Healthcare Ca'ital Mar(et)

S T R A T E G I C P A R T N E R I N G P A T H * A +

8/9/2019 Value To__Strategic Partners.pptx

3/12

Healthcares Investment Bank

Healthio),cha ge -or Strategic Part er)

PHASE #%Sector

De.elo'/e t

PHASE !%Po)itio i g

PHASE 0%E gage/e t

PHASE $%Gro1th

PHASE 2%Relatio )hi'

PHASE 2%Data

A al3tic)

S T R A T E G I C P A R T N E R I N G P A T H * A +

8/9/2019 Value To__Strategic Partners.pptx

4/12

Healthcares Investment Bank

PHASE #%

SectorDe.elo'/e t

Selecting Sectors. Assembling EcoSystems. Aggregating Content.

PHASE !%Po)itio i g

Establishing Thought Leadershi ! Strategic "riorities # "rocess

PHASE 0%E gage/e t

Building $ialogue %ith Broad &niverse o' Targets

PHASE 2%Relatio )hi'

Solidi'ying Commitments %ith "riority ( ortunities

PHASE 2%BIGData

Trending. "redictions. Sentiment Analysis. ( inion )arking.

PHASE $%Gro1th

Taking Action.

Healthio),cha ge -or Strategic Part er)

8/9/2019 Value To__Strategic Partners.pptx

5/12

Healthcares Investment Bank

Healthio),cha ge -or Strategic Part er)

PHASE #%

SectorDe.elo'/e t

Selection &Segmentation

AssemblingEcoSystems

CompanyListings

Presentations &O/M

Clinical /Market Data

Tagging

PHASE !%Po)itio i g

Strategic Page

Communities &Groups

Clinical &Market esearc!

Sector Pages

"c!ange#Li$eLines%

ntegrate' SocialMe'ia

PHASE 0%E gage/e t

Custom Content

(oti$ications

Pri)ate / Public*aluations

#"c!ange Li)e%+oste' C!at

atings &e)ie,s

E-pert Opinion.ebCasts

PHASE $%Gro1th

OpportunityOrigination

Site *isits

Due Diligence

LO

PHASE 2%Relatio )hi'

Targeting &Tracking

Messaging &Alerts

#Gran' oun's%.ebCast

#S!ark Tank%

"c!angeCon$erences

PHASE 2%

BIGData

0 million DataPoints

12333 ConcurrentE-periments

Tren'ing &Acti)ity Scores

Milestones &n$lection Points

Sentiment &Pre'iction

8/9/2019 Value To__Strategic Partners.pptx

6/12

Healthcares Investment Bank

PHASE #% Sector De.elo'/e t

Segmentation &

Selection

AssemblingEcoSystems

CompanyListings

Presentations &O/M

Clinical /Market Data

Tagging

8/9/2019 Value To__Strategic Partners.pptx

7/12 Healthcares Investment Bank

PHASE !% Po)itio i g

Strategic Page

Communities &Groups

Clinical &Market esearc!

Sector Pages

"c!ange#Li$eLines%

ntegrate' SocialMe'ia

8/9/2019 Value To__Strategic Partners.pptx

8/12 Healthcares Investment Bank

Pha)e 0% E gage/e t

Custom Content

(oti$ications

Pri)ate / Public*aluations

Matc!ing &GeoLocation

atings &e)ie,s

.ebCasts &C!at

8/9/2019 Value To__Strategic Partners.pptx

9/12 Healthcares Investment Bank

Pha)e 2% Relatio )hi')

Targeting &

Tracking

Messaging &Alerts

#Gran' oun's%.ebCast

#S!ark Tank%

"c!angeCon$erences

8/9/2019 Value To__Strategic Partners.pptx

10/12 Healthcares Investment Bank

Pha)e $% BIG Data

Merger and acquisition prediction. Note that

confidence is a bit smallerthan 1.

The actualnumber of

months beforethe nexttransaction is 4.We predicted 3.

The actual numberof months before

the nexttransaction is 11.We predicted 10.

The actual value of the nexttransaction is 1!0 millionand "e predicted 1!0million.

The actual value of the next transaction is #1.$!million and "e predicted #1.$! million.

Target/Issuer NovekoInternational Inc.Sector Diagnostic ImagingState QuebecCountry CanadaT1_Type Private PlacementT1_Total_Value 2.41

Months from T1 and T2 13T2_Type Private PlacementT2_Total_Value 2.68

Months from T2 and T3 8T3_Type Private PlacementT3_Total_Value 1.89

Next Transaction value( !"#"N$%& 21.65

Next Transaction value('! )"CT )& 21.65

'rediction confidence .91 6

T%pe of event&When is it going to happen&

'o" big "ill it be&0 million DataPoints

12333 ConcurrentE-periments

Tren'ing &Acti)ity Scores

Milestones &n$lection Points

Sentiment &Pre'iction

8/9/2019 Value To__Strategic Partners.pptx

11/12

Healthcares Investment Bank

Pha)e 4% Gro1th

Opportunity

Origination

Site *isits

Due Diligence

LO

456723332333

Complete' a strategic partners!ip ,it!

T+E 8(DE S G(ED ACTED AS E"CL8S *E9 (A(C AL AD* SO TO (SP AT O(

INSPIRATION

BIOPHARMACEUTICALS5 INC6

8/9/2019 Value To__Strategic Partners.pptx

12/12

Healthcares Investment Bank

Healthio),cha ge -or Strategic Part er)

PHASE #%

SectorDe.elo'/e t

Co/'a 3Pro-ile

Selection &Segmentation

AssemblingEcoSystems

CompanyListings

Presentations &O/M

Clinical /Market Data

Tagging

PHASE !%Po)itio i g

StrategicPro-ile

Strategic Page

Communities &Groups

Clinical &Market esearc!

Sector Pages

"c!angeTimeline

ntegrate' SocialMe'ia

PHASE 0%E gage/e t

Goi gSocial

"c!ange#Li$eLines%

(oti$ications

Pri)ate / Public*aluations

#"c!ange Li)e%+oste' C!at

atings &e)ie,s

E-pert Opinion.ebCasts

PHASE $%Gro1th

Clo)e

Deal Selection

Site *isits

Due Diligence

LO

PHASE 2%Relatio )hi'

DealSelectio

Targeting &Tracking

Messaging &Alerts

#Gran' oun's%.ebCast

#S!ark Tank%

"c!angeCon$erences

PHASE 2%

DataA al3tic)

Ta(i gActio

0 million DataPoints

12333 ConcurrentE-periments

Tren'ing &Acti)ity Scores

Milestones &n$lection Points

Sentiment &Pre'iction